SGLT2 inhibitors confer greater risk reductions for major adverse cardiovascular events in older adults with type 2 diabetes compared with younger adults, according to findings from a systematic ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications consumed more than 80% of Medicare Part D spending, researchers reported.

S Ezzat is a Professor of Medicine and Oncology at The Freeman Centre for Endocrine Oncology, Mount Sinai Hospital, Toronto; and Head of Endocrine Oncology at Princess Margaret Hospital ...

Foreword: Obesity, obesities and gastrointestinal cancers.

Oct. 22, 2024 — Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and ... Oct. 17, 2024 ...

Our findings emphasise that IIM is a multisystem inflammatory disease and will help inform prognosis and clinical management of patients. The idiopathic inflammatory myopathies (IIM), or ‘myositis ...